title: The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms.
abstract: OBJECTIVE
  To determine how the withdrawal from the market of the rotavirus vaccine has affected physicians' trust in vaccine safety mechanisms, future adherence to vaccine recommendations, and willingness to use a new rotavirus vaccine.
  
  
  METHODS
  National survey mailed to 1228 randomly selected pediatricians and family physicians.
  
  
  METHODS
  Confidence in vaccine safety mechanisms was defined by agreement with the statements that the system for determining vaccine safety before a vaccine is licensed works well and that the system for monitoring vaccine safety after vaccine licensure works well. Physicians who indicated that they would use a new rotavirus vaccine within 1 year of licensure and recommendation by professional organizations were classified as "early adopters." Logistic regression was used to assess the relationship between trust in vaccine safety mechanisms and future early adoption of new rotavirus vaccines.
  
  
  RESULTS
  Following the withdrawal of the rotavirus vaccine, 83% of respondents believed the postlicensure surveillance system works well to monitor vaccine safety, while 22% of respondents believed the prelicensure system works well to determine vaccine safety. After adjusting for physician specialty and years in practice, respondents who believed the prelicensure vaccine safety system works well were significantly more likely to be early adopters than those with less confidence in prelicensure studies (adjusted odds ratio, 2.2 [95% confidence interval, 1.3-3.6]).
  
  
  CONCLUSIONS
  Physicians have different levels of trust in prelicensure studies that determine vaccine safety and postlicensure surveillance systems that monitor vaccine safety. Trust in prelicensure vaccine safety evaluations may be associated with early adherence to new vaccine recommendations.
authors.affiliation: Child Health Institute, Department of Pediatrics, School of Medicine, University of Washington, Seattle, 98105, USA. hmcphil@u.washington.edu
authors.forename: H A
authors.initials: HA
authors.lastname: McPhillips
authors.forename: R L
authors.initials: RL
authors.lastname: Davis
authors.forename: E K
authors.initials: EK
authors.lastname: Marcuse
authors.forename: J A
authors.initials: JA
authors.lastname: Taylor
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000331:legislation & jurisprudence*; D001291:Attitude of Health Personnel; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010372:Pediatrics; D011320:Primary Health Care; D011358:Product Surveillance, Postmarketing; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D012449:Safety; D014481:United States
chemical_list: D022243:Rotavirus Vaccines